Liposome/Exosome Hybrid Loaded with FGF2 mRNA for Diabetic Wound Healing
ACS Applied Materials & Interfaces · 2026
DOI: 10.1021/acsami.5c25924 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2026. Verfasst von Muyaxin Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Chemical Engineering, Southeast University, Nanjing 211189, PR China. Hauptthemen laut MEDLINE: Liposomes, Wound Healing, RNA, Messenger, Fibroblast Growth Factor 2. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Jiangsu Provincial Key Research and Development Program.
Themen: Wundversorgung
Abstract (Originalsprache)
Diabetic foot ulcer (DFU) is a severe complication of diabetes, characterized by impaired healing due to chronic inflammation, poor blood vessel growth, and compromised cell function. To improve DFU healing, we create a FGF2 mRNA loaded liposome/exosome hybrid (FGF2-LEH) with dual functions of tissue regrowth and inflammation regulation. The FGF2-LEH was fabricated by incubating FGF2 mRNA with liposomes to form the FGF2-Lipo complex, followed by hybridization with platelet-rich plasma-derived exosomes (PRP-Exos) through freeze-thaw cycle and extrusion. Characterizations demonstrated that the FGF2-LEH had suitable particle size, high encapsulation efficiency, and biosafety. In vitro experiments revealed that FGF2-LEH enhanced the migration and tube formation of human umbilical vein endothelial cells, highlighting its pro-angiogenic potential. In both type 1 and type 2 diabetic mouse models, a single dose of FGF2-LEH greatly accelerated wound healing. After 15 days, the healing rate of the FGF2-LEH group exceeded 96% with improved granulation tissue growth, which was superior to that of control. Histopathological analysis further confirmed that FGF2-LEH promoted CD31+ angiogenesis, increased collagen deposition, and induced macrophages toward M2 polarization, thereby improving anti-inflammatory effect. Taken together, FGF2-LEH combining the advantages of PRP-Exos and FGF2 mRNA provides an approach for DFU treatment with translational potential for clinical application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemistry and Chemical Engineering, Southeast University, Nanjing 211189, PR China.
ORCID-Profile: Xinsong Li
Förderung
- Jiangsu Provincial Key Research and Development Program
Zitieren
APA
Wang, M., Xue, W., Liu, J., Jiang, Y., Luo, J., Shi, S., Yin, X., & Li, X. (2026). Liposome/Exosome Hybrid Loaded with FGF2 mRNA for Diabetic Wound Healing. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.5c25924
Vancouver
Wang M, Xue W, Liu J, Jiang Y, Luo J, Shi S, et al. Liposome/Exosome Hybrid Loaded with FGF2 mRNA for Diabetic Wound Healing. ACS Applied Materials & Interfaces. 2026. doi:10.1021/acsami.5c25924
BibTeX
@article{Wang2026,
author = {Wang, Muyaxin and Xue, Wenliang and Liu, Jinyu and Jiang, Yuhao and Luo, Jianhong and Shi, Shasha and Yin, Xudong and Li, Xinsong},
title = {Liposome/Exosome Hybrid Loaded with FGF2 mRNA for Diabetic Wound Healing},
journal = {ACS Applied Materials & Interfaces},
year = {2026},
doi = {10.1021/acsami.5c25924}
}
EUVIMED